Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese”

753 trials

Showing 20 of 753 results

Early research (Phase 1)Study completedNCT02104765
What this trial is testing

LY2951742 in Healthy Japanese and Caucasian Participants

Who this might be right for
Migraine Disorders
Eli Lilly and Company 45
Early research (Phase 1)Study completedNCT04532567
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

Who this might be right for
Healthy
Galapagos NV 32
Early research (Phase 1)Study completedNCT04079101
What this trial is testing

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy Volunteers
Biogen 31
Early research (Phase 1)Study completedNCT01568281
What this trial is testing

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

Who this might be right for
SafetyPharmacokinetics
AstraZeneca 58
Early research (Phase 1)Study completedNCT00912353
What this trial is testing

AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects

Who this might be right for
Healthy
AstraZeneca 56
Early research (Phase 1)Study completedNCT03259464
What this trial is testing

This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated

Who this might be right for
Healthy
Boehringer Ingelheim 72
Early research (Phase 1)Study completedNCT01390714
What this trial is testing

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

Who this might be right for
Gastroesophageal Reflux Disease
Eisai Co., Ltd. 30
Early research (Phase 1)WithdrawnNCT02322606
What this trial is testing

A Phase 1, Single and Multiple Dose Study of TAK-137

Who this might be right for
Healthy Japanese Adult Male
Takeda
Early research (Phase 1)Study completedNCT01116011
What this trial is testing

Multiple Ascending Dose Study for AZD 7268 in Japanese Healthy Male Volunteers

Who this might be right for
Healthy
AstraZeneca 30
Early research (Phase 1)Study completedNCT00543946
What this trial is testing

Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males

Who this might be right for
Arrhythmia
Wyeth is now a wholly owned subsidiary of Pfizer 56
Early research (Phase 1)Study completedNCT01202734
What this trial is testing

A Pharmacokinetics and Safety of Methylphenidate HCl in Healthy Japanese Adult Male Volunteers

Who this might be right for
Healthy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 10
Early research (Phase 1)Study completedNCT01216384
What this trial is testing

Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian Volunteers

Who this might be right for
AsthmaRhinitis, Allergic, Perennial
Boehringer Ingelheim 73
Early research (Phase 1)Study completedNCT05105048
What this trial is testing

Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Who this might be right for
Cytomegalovirus Infection
ModernaTX, Inc. 9
Post-approval studies (Phase 4)Study completedNCT01804244
What this trial is testing

A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Early research (Phase 1)Study completedNCT00653822
What this trial is testing

Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers

Who this might be right for
Pharmacokinetics of Alefacept
Astellas Pharma Inc 75
Early research (Phase 1)Study completedNCT05288816
What this trial is testing

Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT03436849
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESN364 in Healthy Japanese Male and Pre- and Post-menopausal Female Subjects

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 44
Early research (Phase 1)Study completedNCT03642847
What this trial is testing

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age

Who this might be right for
Pneumococcal Infections
Pfizer 104
Early research (Phase 1)Study completedNCT04765553
What this trial is testing

Evaluate Emapalumab in Japanese Healthy Volunteers.

Who this might be right for
Rare Diseases
Swedish Orphan Biovitrum 8
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation